Flyer

Archives of Clinical Microbiology

  • ISSN: 1989-8436
  • Journal h-index: 24
  • Journal CiteScore: 8.01
  • Journal Impact Factor: 7.55
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • Open Archive Initiative
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
  • Scimago Journal Ranking
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Towards the treatment and prevention of invasive non-typhoidal Salmonella infections

10th Edition of International Conference on Advanced Microbiology & Education
June 14-16, 2018 London, UK

Manal Mohammed

University of Westminster, UK

Keynote: Arch Clin Microbiol

Abstract:

This lecture will address strategies to develop novel therapeutics against invasive non-typhoidal Salmonella infections. Salmonellosis is one of the most common foodborne diseases worldwide that causes a huge burden of morbidity and mortality in humans. Although non-typhoidal Salmonella serovars including Salmonella Typhimurium and Salmonella Dublin are associated primarily with self-limiting gastrointestinal illness they have adapted to cause invasive disease in humans particularly children, elderly and immunocompromised people. It is estimated that 680,000 people die every year as a result of infection by invasive non-typhoidal Salmonella. Interestingly, non-typhidal Salmonella have developed multi-drug resistance against current antibiotics including the last resource, colistin. Bacteriophage therapy is therefore the hope for the treatment of multidrug resistant infections however one of the key limitations to therapeutic use of phages, in particular for empiric therapy of infections, is the limited host range of many phages and the ease of development of bacterial resistance to phages. A solution may be to develop one or a cocktail of engineered phage that overcome some of these limitations. An essential step towards this goal is greater understanding of the complex dynamics of bacteriaphage interaction. We therefore use Anderson phage typing scheme of Salmonella Typhimurium as it provides a valuable model system for study of phage-host interaction and it will help us to characterize all bacterial antiviral systems and phage evasion strategies. The project will provide new insights into phage biology and strategies for genetic modification of phages and designing of effective broad spectrum engineered phages to overcome the limitations of bacteriophages as therapeutic agents. There is no vaccine against non-typhoidal Salmonella however our understanding of the molecular basis of virulence in invasive Salmonella Dublin using next generation sequencing technologies and associated bioinformatics associated tools will provide insights into the development of an effective vaccine through identification of novel virulence-attenuated strains with a potential for use as vaccine candidates for high-risk groups. Recent Publications 1. Mohammed M (2017) Phage typing or CRISPR typing for epidemiological surveillance of Salmonella Typhimurium?. BMC Res. Notes 10(1):578. 2. Mohammed M et al. (2017) The invasome of Salmonella Dublin as revealed by whole genome sequencing. BMC Infect. Dis. 17(1):544. 3. Mohammed M and M Cormican (2016) Whole genome sequencing provides insights into the genetic determinants of invasiveness in Salmonella Dublin. Epidemiol. Infect. 144(11):2430-2439. 4. Mohammed M et al. (2016) Whole genome sequencing provides an unambiguous link betweenSalmonella Dublin outbreak strain and a historical isolate. Epidemiol. Infect. 144(3):576-81. 5. Mohammed M and M Cormican (2015) Whole genome sequencing provides possible explanations for the difference in phage susceptibility among two Salmonella Typhimurium phage types (DT8 and DT30) associated with a single foodborne outbreak. BMC Res. Notes. 8:728.

Biography :

Manal Mohammed (BVSc, MVSc, PhD, FHEA) did her PhD in medical microbiology at University of Liverpool where she studied the molecular evolution of incurable Japanese encephalitis virus associated with high morbidity and mortality in humans. She tested the efficacy of intravenous immunoglobulins on inhibition of virus growth, she also discovered a new genotype of the virus. After she got her PhD Manal’s research interests now include application of next generation sequencing technologies and associated bioinformatics analyses tools in investigating the molecular basis of virulence of non typhoidal salmonellosis in humans and understanding the complex dynamics of bacteria-phage interaction aiming to develop phage therapy as an alternative to antibiotics.

E-mail: m.mohammed1@westminster.ac.uk